Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,175,320
+$102,474 QoQ
Shares Held
7,769
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#359
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $326,555,377 across 9 Diagnostics & Research names. LH ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
264,936 | $132,828,312 | |
| 2 | DHR |
Danaher Corp /De/
|
585,734 | $111,570,612 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
104,140 | $54,823,461 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
69,136 | $13,358,457 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
7,218 | $9,221,067 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
7,769 | $2,175,320 | |
| 7 | WAT |
Waters Corp /De/
|
4,986 | $1,869,949 | |
| 8 | ILMN |
Illumina, Inc.
|
2,216 | $389,639 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,175,320 | 7,769 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,072,846 | 7,769 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,949,086 | 7,769 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,230,169 | 7,769 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,090,892 | 7,965 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,860,290 | 7,993 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,832,954 | 7,993 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,562,795 | 6,993 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||